BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2573419)

  • 1. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
    Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
    Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers.
    Freeman MR; Washecka R; Chung LW
    Cancer Res; 1989 Nov; 49(22):6221-5. PubMed ID: 2572319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
    Lacroix H; Iglehart JD; Skinner MA; Kraus MH
    Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
    Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
    Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
    Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
    Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
    Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancer.
    Holzmann K; Welter C; Klein V; Pistorius G; Seitz G; Blin N
    Anticancer Res; 1992; 12(3):1013-8. PubMed ID: 1352439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
    Hynes NE
    Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
    Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J
    Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X; Silva E; Gershenson D; Hung MC
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplification in gastric and esophageal adenocarcinomas.
    Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen DP; Chaganti RS
    Cancer Res; 1990 Oct; 50(19):6417-22. PubMed ID: 2400999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.